Bayer has taken a major step towards commercialising hybrid wheat after signing an exclusive licensing agreement with French seed breeder RAGT, strengthening its position in a crop market that it believes could become a billion-euro business.
The agreement gives Bayer access to RAGT’s elite wheat genetics and breeding expertise for the European market, supporting its ambition to launch hybrid wheat seeds in both Europe and North America by the early 2030s.
For Bayer, the deal is about far more than adding another crop to its seed portfolio. The company sees hybrid wheat as one of the largest remaining growth opportunities in global agriculture. Wheat remains the world’s most widely grown food crop, covering more than 220 million hectares globally and providing around 30% of the world’s calories. Yet despite its importance, commercial adoption of hybrid wheat has remained limited compared with crops such as maize.
Bayer believes this is set to change. The company has said hybrid wheat could deliver annual revenues of up to €1 billion within a little more than a decade of launch, making it a key pillar of its next wave of growth beyond its current portfolio of blockbuster products.
The announcement follows a major milestone for the sector earlier this year, when Syngenta unveiled what it described as Europe’s first scalable hybrid wheat programme, highlighting intensifying competition among major crop science companies to commercialise hybrid wheat in Europe.
Why hybrid wheat matters
Hybrid wheat is often described as the wheat equivalent of hybrid maize.
It is produced by crossing two genetically distinct parent lines to create a high-performance offspring that combines desirable traits from both parents.
The result can be higher yields, greater resilience and improved resource-use efficiency.
The challenge for breeders has been making hybrid seed production reliable and economical in a crop that naturally self-pollinates. While hybrid maize became commercially established decades ago, hybrid wheat has long been viewed as one of crop breeding’s most difficult challenges.
For companies that can crack the code, however, the opportunity is enormous.
According to RAGT, hybrid wheat can increase production by around 10% compared with conventional open-pollinated varieties, even during the early stages of commercial adoption, with additional genetic gains expected over time.
Growers may also benefit from stronger root systems, faster establishment, improved tolerance to disease, weeds and pests, and greater resilience to drought and heat.
Those attributes are becoming increasingly valuable as weather extremes put pressure on wheat production across major growing regions.
Strengthening Bayer’s hand in Europe
Bayer and RAGT have collaborated on hybrid wheat research for several years, but the new agreement significantly deepens the relationship.
Bayer said the deal materially strengthens its position in Europe because it provides broad access to wheat germplasm specifically adapted to European growing conditions.
That genetic foundation will be combined with Bayer’s existing hybrid wheat breeding programme, seed production expertise and digital agriculture capabilities.
“Wheat is one of the most important staple food crops in the world. But wheat production has stagnated and is coming under pressure from prolonged drought and heatwaves, such as the one we just experienced in Europe,” said Peter Mueller, Cereals, Cotton, Canola/OSR & Biofuels Lead at Bayer’s Crop Science division.
“At the same time, sturdier hybrid varieties of wheat are still not widely available.
“Our deal with RAGT is about to change that. Combining RAGT’s top-performing germplasm and know-how with our breeding capabilities will significantly boost and expand our pipeline of hybrid wheat varieties, allowing us to compete in a rapidly evolving market.”
The company believes the genetic material covered by the agreement has the potential to fit more than 80% of wheat hectares across Europe and the United States.
Building a transatlantic wheat franchise
Bayer plans to pursue a dual-market strategy.
In Europe, the company’s efforts will focus primarily on winter wheat. In North America, Bayer intends to introduce both winter and spring wheat varieties through its existing WestBred wheat franchise.
The strategy reflects Bayer’s ambition to build what it describes as a holistic wheat production system, combining genetics, crop protection products, seed production expertise, agronomic advice and digital farming tools.
The company already holds a strong position in wheat crop protection and believes that combining those customer relationships with access to elite germplasm gives it a competitive advantage as hybrid wheat moves towards commercial reality.
A shared vision for wheat’s future
For RAGT, one of Europe’s largest seed breeders and a leading force in wheat genetics, the agreement represents an opportunity to accelerate development of hybrid wheat across the industry.
“We’re very excited about the potential of this broad licensing agreement with Bayer, as it represents a significant step in RAGT’s commitment to innovation in wheat breeding,” said Sébastien Chatre, Head of R&D at RAGT.
“By sharing our expertise, we can accelerate the development of hybrid wheat solutions that will benefit the entire market and meet the evolving needs of farmers and the seed industry.”
Chatre said the deal reflects the value of the wheat genetics RAGT has developed over decades and reinforces the company’s long-term commitment to hybrid wheat research.
“Our ambition remains unchanged: to help develop new generations of hybrid wheat capable of meeting the agronomic, economic and environmental challenges facing farmers.”
Betting on resilience
Ultimately, Bayer’s interest in hybrid wheat comes down to a simple calculation: demand for wheat continues to grow while production faces mounting pressure from climate change.
With hotter temperatures, more frequent droughts and increasing yield volatility, breeders are searching for technologies capable of improving both productivity and resilience.
Hybridisation could offer one of the most powerful tools available.
“We are beyond excited to have signed that agreement, that grants us access to RAGT’s excellent genetic material,” said Constance Tuffet, Bayer’s Cereals Strategy Lead.
“There is something even more special about achieving this with RAGT, with whom we share a common vision on hybrid wheat.”